Literature DB >> 16906156

Role of deficient type III interferon-lambda production in asthma exacerbations.

Marco Contoli1, Simon D Message, Vasile Laza-Stanca, Michael R Edwards, Peter A B Wark, Nathan W Bartlett, Tatiana Kebadze, Patrick Mallia, Luminita A Stanciu, Hayley L Parker, Louise Slater, Anita Lewis-Antes, Onn M Kon, Stephen T Holgate, Donna E Davies, Sergei V Kotenko, Alberto Papi, Sebastian L Johnston.   

Abstract

Rhinoviruses are the major cause of asthma exacerbations, and asthmatics have increased susceptibility to rhinovirus and risk of invasive bacterial infections. Here we show deficient induction of interferon-lambdas by rhinovirus in asthmatic primary bronchial epithelial cells and alveolar macrophages, which was highly correlated with severity of rhinovirus-induced asthma exacerbation and virus load in experimentally infected human volunteers. Induction by lipopolysaccharide in asthmatic macrophages was also deficient and correlated with exacerbation severity. These results identify previously unknown mechanisms of susceptibility to infection in asthma and suggest new approaches to prevention and/or treatment of asthma exacerbations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906156     DOI: 10.1038/nm1462

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  433 in total

Review 1.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

2.  Interferon-λ1 and viral wheeze in asthma: a Gothic duality?

Authors:  James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2012-03-01       Impact factor: 21.405

Review 3.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

Review 4.  Autophagy in innate and adaptive immunity.

Authors:  Yi Xu; N Tony Eissa
Journal:  Proc Am Thorac Soc       Date:  2010-02

5.  Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma.

Authors:  Lyndsey M Muehling; Peter W Heymann; Paul W Wright; Jacob D Eccles; Rachana Agrawal; Holliday T Carper; Deborah D Murphy; Lisa J Workman; Carolyn R Word; Sarah J Ratcliffe; Brian J Capaldo; Thomas A E Platts-Mills; Ronald B Turner; William W Kwok; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2020-04-19       Impact factor: 10.793

6.  Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor alpha induction in human epithelial cells.

Authors:  Kelly L McCann; Farhad Imani
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

7.  Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis.

Authors:  A Głobińska; M Pawełczyk; A Piechota-Polańczyk; A Olszewska-Ziąber; S Moskwa; A Mikołajczyk; A Jabłońska; P K Zakrzewski; M Brauncajs; M Jarzębska; S Taka; N G Papadopoulos; M L Kowalski
Journal:  Clin Exp Immunol       Date:  2016-11-14       Impact factor: 4.330

Review 8.  What does tympanostomy tube placement in children teach us about the association between atopic conditions and otitis media?

Authors:  Young J Juhn; Chung-Il Wi
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

Review 9.  Cell Death in the Lung: The Apoptosis-Necroptosis Axis.

Authors:  Maor Sauler; Isabel S Bazan; Patty J Lee
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

10.  Increased risk of herpes zoster in children with asthma: a population-based case-control study.

Authors:  Bong-Seong Kim; Sonia Mehra; Barbara Yawn; Charles Grose; Robert Tarrell; Brian Lahr; Young J Juhn
Journal:  J Pediatr       Date:  2013-04-13       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.